We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
I Agree
Email registered. Please sign in.×
Enter your contact to build trust with supplier(s)×
One More Step to Finalize Your Registration
An activation link has been sent to your email address.
Please check the email and activate your account now. It might take few minutes to get the email.
If you did not find it, please check your spam box.
Having problem receiving the email? Send again
Still cannot receive? Contact us
Email ：PharmaSources@imsinoexpo.com
Whatsapp ：+86-13621645194
Baynoe is a high-tech enterprise specialized in the research and development, production, and sales of new organic luminescent materials (OLED) and other electronic chemicals. The company was founded by a technical team with many years of experience in the synthesis of electronic chemicals. Currently, the company is building a 2000 square meter professional product research and development center in Suzhou Industrial Park, a sales center in Shanghai, a production base of over 2000 square meters in Hubei, and a specialized production factory of over 3500 square meters in Zhangjiagang. The annual production capacity of OLED intermediates or materials is 30 tons.
To date, the company's research and development center has developed a total of 2500 new products, with an annual increase of 300 to 500 new products, and the production base has successfully launched more than 30 mass production projects. The products cover various types of OLED molecular structures, such as carbazole, diphenyl-furan, diphenyl-thiophene, triazine, phenanthrene, anthracene, pyrene, amine, naphthalene, boronic acid, and deuterated products.
Audited Supplier
![[1,1':3',1''-terphenyl]-4'-amine](https://eimg.pharmasources.com/image/product/20240724/fc6ca62476b9c03fe2fc45eccb259609jpg!280)
![N,4'-diphenyl-[1,1':2',1'':4'',1'''-quaterphenyl]-4'''-amine](https://eimg.pharmasources.com/image/product/20240724/aba94aef6d761783de3b3c3458b98b7bjpg!280)
![N-([1,1'-biphenyl]-4-yl)-[1,1':2',1''-terphenyl]-2-amine](https://eimg.pharmasources.com/image/product/20240724/d249f000bbf48e5c4b2d62adcd4d9f7ejpg!280)
![N-([1,1'-biphenyl]-3-yl)-[1,1':4',1''-terphenyl]-4-amine](https://eimg.pharmasources.com/image/product/20240724/d0a93684fac82af7ef765417558567efjpg!280)
![N-phenyl-[1,1':2',1''-terphenyl]-4-amine](https://eimg.pharmasources.com/image/product/20240724/8c1182bcfc8a9e75dba8bd64b0d3b065jpg!280)
![N-([1,1'-biphenyl]-4-yl)-[1,1':2',1''-terphenyl]-4-amine](https://eimg.pharmasources.com/image/product/20240724/a10bba5f8532d9c0c85308d8f251af3cjpg!280)
![N-phenyl-[1,1':4',1''-terphenyl]-3-amine](https://eimg.pharmasources.com/image/product/20240724/35e4c484a243edeaa6d5e43b3f1880bejpg!280)
![2-(1-(2-(2-methoxyethoxy)ethyl)hydrazinyl)benzo[d]thiazole](https://eimg.pharmasources.com/image/product/20240724/703c7d8bc7f4496646abde188528087cjpg!280)
Pharma Sources Insight June 2024: Globalization on the Go
